Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Issam Zineh

Showing results (61-70 of 127) with videos related to

Pageof 13
Sort By:
Pharmacotherapy|September 2, 2006
Discordant beta-blocker effects on clinic, ambulatory, resting, and exercise hemodynamics in patients with hypertensionAmber L Beitelshees, Issam Zineh, Hossein N Yarandi, et al.
Therapeutic Delivery|July 27, 2012
Biomarkers to improve the benefit/risk balance for approved therapeutics: a US FDA perspective on personalized medicineKim E Sapsford, Zivana Tezak, Marina Kondratovich, et al.
Journal of Lipid Research|June 8, 2010
High-dose atorvastatin causes a rapid sustained increase in human serum PCSK9 and disrupts its correlation with LDL cholesterolGreg Welder, Issam Zineh, Michael A Pacanowski, et al.
American Journal of Hypertension|May 2, 2009
Genetic and pharmacogenetic associations between NOS3 polymorphisms, blood pressure, and cardiovascular events in hypertensionMichael A Pacanowski, Issam Zineh, Rhonda M Cooper-Dehoff, et al.
Journal of Pharmaceutical Sciences|November 3, 2018
Physiologically Based Pharmacokinetic Modeling in Regulatory Science: An Update From the U.S. Food and Drug Administration's Office of Clinical PharmacologyManuela Grimstein, Yuching Yang, Xinyuan Zhang, et al.
Journal of Clinical Pharmacology|January 23, 2015
Canagliflozin use in patients with renal impairment-Utility of quantitative clinical pharmacology analyses in dose optimizationManoj Khurana, Jayabharathi Vaidyanathan, Anshu Marathe, et al.
Human Reproduction (Oxford, England)|August 8, 2006
Doxycycline alters the expression of inflammatory and immune-related cytokines and chemokines in human endometrial cells: implication in irregular uterine bleedingRongxiu Li, Xiaoping Luo, Qun Pan, et al.
The Journal of Clinical Psychiatry|October 13, 2012
CYP2D6 genotype information to guide pimozide treatment in adult and pediatric patients: basis for the U.S. Food and Drug Administration's new dosing recommendationsHobart L Rogers, Atul Bhattaram, Issam Zineh, et al.
Clinical Pharmacology and Therapeutics|July 5, 2003
Beta 1-adrenergic receptor polymorphisms and antihypertensive response to metoprololJulie A Johnson, Issam Zineh, Brian J Puckett, et al.
Pharmacotherapy|October 27, 2006
Atorvastatin effect on circulating and leukocyte-produced CD40 ligand concentrations in people with normal cholesterol levels: a pilot studyIssam Zineh, Gregory J Welder, Amy E DeBella, et al.
Pageof 13

Showing results (61-70 of 127) with videos related to

Sort By:
Pageof 13
Pharmacotherapy|September 2, 2006
Discordant beta-blocker effects on clinic, ambulatory, resting, and exercise hemodynamics in patients with hypertensionAmber L Beitelshees, Issam Zineh, Hossein N Yarandi, et al.
Therapeutic Delivery|July 27, 2012
Biomarkers to improve the benefit/risk balance for approved therapeutics: a US FDA perspective on personalized medicineKim E Sapsford, Zivana Tezak, Marina Kondratovich, et al.
Journal of Lipid Research|June 8, 2010
High-dose atorvastatin causes a rapid sustained increase in human serum PCSK9 and disrupts its correlation with LDL cholesterolGreg Welder, Issam Zineh, Michael A Pacanowski, et al.
American Journal of Hypertension|May 2, 2009
Genetic and pharmacogenetic associations between NOS3 polymorphisms, blood pressure, and cardiovascular events in hypertensionMichael A Pacanowski, Issam Zineh, Rhonda M Cooper-Dehoff, et al.
Journal of Pharmaceutical Sciences|November 3, 2018
Physiologically Based Pharmacokinetic Modeling in Regulatory Science: An Update From the U.S. Food and Drug Administration's Office of Clinical PharmacologyManuela Grimstein, Yuching Yang, Xinyuan Zhang, et al.
Journal of Clinical Pharmacology|January 23, 2015
Canagliflozin use in patients with renal impairment-Utility of quantitative clinical pharmacology analyses in dose optimizationManoj Khurana, Jayabharathi Vaidyanathan, Anshu Marathe, et al.
Human Reproduction (Oxford, England)|August 8, 2006
Doxycycline alters the expression of inflammatory and immune-related cytokines and chemokines in human endometrial cells: implication in irregular uterine bleedingRongxiu Li, Xiaoping Luo, Qun Pan, et al.
The Journal of Clinical Psychiatry|October 13, 2012
CYP2D6 genotype information to guide pimozide treatment in adult and pediatric patients: basis for the U.S. Food and Drug Administration's new dosing recommendationsHobart L Rogers, Atul Bhattaram, Issam Zineh, et al.
Clinical Pharmacology and Therapeutics|July 5, 2003
Beta 1-adrenergic receptor polymorphisms and antihypertensive response to metoprololJulie A Johnson, Issam Zineh, Brian J Puckett, et al.
Pharmacotherapy|October 27, 2006
Atorvastatin effect on circulating and leukocyte-produced CD40 ligand concentrations in people with normal cholesterol levels: a pilot studyIssam Zineh, Gregory J Welder, Amy E DeBella, et al.
Pageof 13